Cause of death for people with end-stage kidney disease withdrawing from treatment in Australia and New Zealand

Our study objective was to estimate treatment withdrawal death rates within the Australian and New Zealand ESKD population, as well as to compare the underlying cause of death between the national death register and the Australian and New Zealand Dialysis and Transplant Registry (ANZDATA).

Find full text here: Cause of death for people with end-stage kidney disease withdrawing from treatment in Australia and New Zealand

Epidemiology of cardiovascular death in kidney failure: An Australian and New Zealand cohort study using data linkage

• Our study objective was to describe the epidemiology of cardiovascular death (specifically cardiac and peripheral vascular deaths excluding stroke) across the lifespan of KF. In particular, we aimed to understand the effects of multimorbidity and KRT modality on cardiovascular mortality rates. We further aimed to characterize changes in cardiovascular death across treatment era.

See full text here: Epidemiology of cardiovascular death in kidney failure: An Australian and New Zealand cohort study using data linkage

Sex differences in mortality among binational cohort of people with chronic kidney disease: population based data linkage study

Our study aimed to evaluate sex differences in mortality in the Australian and New Zealand population with kidney failure by using relative measures of survival to account for expected background mortality in the general population. We hypothesised that people with kidney failure would have greater mortality than the general population, and sought to explore whether the impact of kidney failure on excess mortality was comparable between sexes.

Find full text here: Sex differences in mortality among binational cohort of people with chronic kidney disease: population based data linkage study

Cardiac Mortality in Transplant Patients; A Population-Based Cohort Study 1988-2013 in Australia and New Zealand

• Transplant recipients experience excess cardiac mortality. We compared circulatory death rates in Australian and New Zealand kidney transplant recipients to the general population and identified risk factors for circulatory death in kidney transplant recipients.

Find the text here: Cardiac Mortality in Transplant Patients; A Population-Based Cohort Study 1988-2013 in Australia and New Zealand

Cancer mortality in kidney transplant recipients: An Australian and New Zealand population‐based cohort study, 1980–2013

We looked at the cause of death for all kidney transplant recipients in Australia and New Zealand 1980-2013. There were 5,284 deaths in 17,628 kidney transplant recipients including 1,061 (20%) cancer deaths. Our study showed cancer mortality in kidney transplant recipients was overall 3 times higher than expected in the general population. The magnitude of excess mortality varied by cancer site, age and sex.

Find the text here: Cancer mortality in kidney transplant recipients: An Australian and New Zealand population‐based cohort study, 1980–2013

Excess Stroke Deaths in Kidney Transplant Recipients: A Retrospective Population-based Cohort Study Using Data Linkage

Among 17 628 kidney transplant recipients, we found 158 deaths from stroke. This was 19 times higher for women and 9 times higher for men than expected in the general population. Higher risk of stroke death was associated with older age at transplant, ever graft failure, earlier era of transplant, pre-existing cerebrovascular disease and no previous malignancy.

Find the text here: Excess Stroke Deaths in Kidney Transplant Recipients: A Retrospective Population-based Cohort Study Using Data Linkage

Survival in Living Kidney Donors: An Australian and New Zealand Cohort Study Using Data Linkage

This paper looked at outcomes from all living kidney donors in Australia, 2004–2013, and New Zealand, 2004–2012. We investigated any deaths that had occurred in living donors, and if they had died, what caused their deaths. As expected, because living donors are only allowed to donate if they are very healthy, their mortality was substantially lower than the general population.  The Living Donor Registry only captured a third of the deaths, highlighting the benefit of data linkage to national death registries in the long-term follow-up of living kidney donors.

Find the text here: Survival in Living Kidney Donors: An Australian and New Zealand Cohort Study Using Data Linkage